BioAtla Inc. is facing a significant regulatory issue after receiving notice from Nasdaq that its securities will be suspended from trading due to non-compliance with the $1.00 minimum bid price requirement and the $2.5 million stockholders' equity requirement. The company had previously met an alternative market value standard but failed to maintain compliance. BioAtla is appealing the delisting determination to the Nasdaq Listing Council, but trading on Nasdaq may be suspended while the appeal is pending. If delisted, BioAtla’s stock is expected to move to the OTCID market, which could negatively affect trading price and volume, and there is no assurance a market for its shares will be maintained.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioAtla Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-041367), on February 06, 2026, and is solely responsible for the information contained therein.